Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils

References

• Freund J. The mode of action of immunologic adjuvants. Adv Tuberc Res. 1956; 7:130–148.
   Google Scholar
• Kleinau S., Erlandsson H., Holmdahl R., Klareskog L.. Adjuvant oils induce arthritis in the DA rat. I. Characterization of the disease and evidence for an immunological involvement. J Autoimmun. 1991; 4:871–880.
   PubMed Web of Science ®Google Scholar
• Kuroda Y., Nacionales D. C., Akaogi J., Reeves W. H., Satoh M.. Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine. Biomed Pharmacother. 2004; 58:325–337.
   PubMed Web of Science ®Google Scholar
• Dahlgren J., Takhar H., Anderson-Mahoney P., Kotlerman J., Tarr J., Warshaw R.. Cluster of systemic lupus erythematosus (SLE) associated with an oil field waste site: a cross sectional study. Environ Health. 2007; 6:8.
   PubMed Web of Science ®Google Scholar
• Sverdrup B., Källberg H., Bengtsson C., . Association between occupational exposure to mineral oil and rheumatoid arthritis: results from the Swedish EIRA case-control study. Arth Res Ther. 2005; 7:R1296–1303.
   Google Scholar
• Calvani N., Caricchio R., Tucci M., . Induction of apoptosis by the hydrocarbon oil pristane: implications for pristane-induced lupus. J Immunol. 2005; 175:4777–4782.
   PubMed Web of Science ®Google Scholar
• Satoh M., Weintraub J. P., Yoshida H.. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J Immunol. 2000; 165:1036–1043.
   PubMed Web of Science ®Google Scholar
• Lee P. Y., Kumagai Y., Li Y., . TLR7-dependent and FcgammaR-independent production of type I interferon in experimental mouse lupus. J Exp Med. 2008; 205:2995–3006.
   PubMed Web of Science ®Google Scholar
• Hoffmann M. H., Hopf R., Niederreiter B., Redl H., Smolen J. S., Steiner G.. Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis. Arthritis Res Ther. 2010; 12:R41.
   Google Scholar
• Vingsbo C., Sahlstrand P., Brun J. G., Jonsson R., Saxne T., Holmdahl R.. Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes. Am J Pathol. 1994; 149:1675–1683.
   Google Scholar
• Janz S., Shacter E.. A new method for delivering alkanes to mammalian cells: preparation and preliminary characterization of an inclusion complex between beta-cyclodextrin and pristane (2,6,10,14-tetramethylpentadecane). Toxicology. 1991; 69:301–315.
   Google Scholar
• Nilsson C., Aboud S., Karlén K., Hejdeman B., Urassa W., Biberfeld G.. Optimal blood mononuclear cell isolation procedures for gamma interferon enzyme-linked immunospot testing of healthy Swedish and Tanzanian subjects. Clin Vaccine Immunol. 2008; 15:585–589.
   PubMed Web of Science ®Google Scholar
• Munoz L. E., Janko C., Grossmayer G. E., . Remnants of Secondarily Necrotic Cells Fuel Inflammation in Systemic Lupus Erythematosus. Arthritis Rheum. 2009; 60:1733–1742.
   PubMed Web of Science ®Google Scholar
• Kuroda Y., Akaogi J., Nacionales D. C., . Distinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci. 2004; 78:222–228.
   PubMedGoogle Scholar
• Satoh M., Reeves W. H.. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med. 1994; 180:2341–2346.
   PubMed Web of Science ®Google Scholar
• Potter M., Boyce C. R.. Induction of plasma-cell neoplasms in strain BALB/c mice with mineral oil and mineral oil adjuvants. Nature. 1962; 193:1086–1087.
   PubMed Web of Science ®Google Scholar
• Satoh M., Kumar A., Kanwar Y. S., Reeves W. H.. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A. 1995; 92:10934–10938.
   PubMed Web of Science ®Google Scholar
• Kleinau S., Dencker L., Klareskog L.. Oil-induced arthritis in DA rats: tissue distribution of arthritogenic 14C-labelled hexadecane. Int J Immunopharmacol. 1995; 17:393–401.
   Google Scholar
• Fuchs T. A., Abed U., Goosman C., . Novel cell death program leads to neutrophil extracellular traps. J Cell Biol. 2007; 176:231–241.
   PubMed Web of Science ®Google Scholar
• Martinon F., Burns K., Tschopp J.. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell. 2002; 10:417–426.
   PubMed Web of Science ®Google Scholar
• Martinon F., Tschopp J.. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ. 2007; 14:10–22.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M., Mueller J. L., Vitari A. C., . Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol. 2009; 187:61–70.
   PubMed Web of Science ®Google Scholar
• Dinarello C. A.. IL-1: Discoveries, controversies and future directions. Eur J Immunol. 2010; 40:599–606.
   PubMed Web of Science ®Google Scholar
• Nash J. F., Gettings S. D., Diembeck W., Chudowski M., Kraus A. L.. A toxicological review of topical exposure to white mineral oils. Food Chem Toxicol. 1996; 34:213–225.
   PubMed Web of Science ®Google Scholar
• Lorentzen J. C.. Identification of arthritogenic adjuvants of self and foreign origin. Scand J Immunol. 1999; 49:45–50.
   Google Scholar
• Allison A. C.. Squalene and squalane emulsions as adjuvants. Methods. 1999; 19:87–93.
   PubMed Web of Science ®Google Scholar
• Hultqvist M., Olofsson P., Gelderman K. A., Holmberg J., Holmdahl R.. A New Arthritis Therapy with Oxidative Burst Inducers. PLoS Med. 2006; 3:e348.
   PubMed Web of Science ®Google Scholar
• Netea M. G., Nold-Petry C. A., Nold M. F., . Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood. 2009; 113:2324–2335.
   PubMed Web of Science ®Google Scholar
• Dinarello C. A., Cannon J. G., Wolff S. M., . Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med. 1986; 163:1433–1450.
   PubMed Web of Science ®Google Scholar
• Coeshott C., Ohnemus C., Pilyavskaya A., . Converting enzyme-independent release of tumor necrosis factor alpha and IL-1beta from a stimulated human monocytic cell line in the presence of activated neutrophils or purified proteinase 3. Proc Natl Acad Sci U S A. 1999; 96:6261–6266.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G., Ku G., Harding M. W., Livingston D. J., Sipe J. D., Kuida K.. Response to local inflammation of IL-1 beta-converting enzyme- deficient mice. J Immunol. 1997; 158:1818–1824.
   PubMed Web of Science ®Google Scholar
• Petrilli V., Papin S., Dostert C., Mayor A., Martinon F., Tschopp J.. Activation of the NALP3 inflammasome is triggered by low intracellular potassium concentration. Cell Death Differ. 2007; 14:1583–1589.
   PubMed Web of Science ®Google Scholar
• Schorn C., Frey B., Lauber K., . Sodium overload and water influx activate the NALP3 inflammasome. J Biol Chem. 2011; 286:35–41.
   PubMed Web of Science ®Google Scholar
• Hainz N., Thomas S., Neubert K., . The Proteasome Inhibitor Bortezomib Prevents Lupus Nephritis in the NZB/W F1 Mouse Model by Preservation of Glomerular and Tubulointerstitial Architecture. Nephron Exp Nephrol. 2012; 120:e47–e58.
   PubMedGoogle Scholar
• Bresnihan B., Alvaro-Gracia J. M., Cobby M., . Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum. 1998; 41:2196–2204.
   PubMed Web of Science ®Google Scholar
• Kolly L., Busso N., Palmer G., . Expression and function of the NALP3 inflammasome in rheumatoid synovium. Immunology. 2010; 129:178–185.
   Google Scholar
• Kolly L., Karababa M., Joosten L. A., . Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1. NALP-3, and IPAF. J Immunol. 2009; 183:4003–4012.
   Google Scholar